Vitiligo BioBank Network
Vitiligo BioBank consists of the principal location and a number of participating biobanks in key regions. They hold collections of biosamples along with clinical profiles of vitiligo patients and annotations on efficacy of vitiligo therapy in combination with different drugs.
- Canada (Vancouver)
- China (Shenyag)
- Croatia (Zagreb)
- Georgia (Tbilisi)
- India (Gujrat, Chandigarh, Mumbai)
- Italy (Florence)
- Kazakhstan (Shymkent)
- Pakistan ()
- Russia (Moscow)
- Tanzania (coming soon)
- USA (Boston, Dallas, Aurora)
Check full contact details at the World Vitiligo Map »
Instead of having samples transferred to some central location, our CloudBank IT-system can track samples at an unlimited number of locations. The samples never have to be moved or handled until they are needed. The originators own their samples, and the VRF guides them in building the collection and participating in research.
The principal Vitiligo Biobank service facility at the Center Of Excellence in Moscow supports basic, translational and industrial research. The VRF considers itself as a research partner rather than a sample provider. The VRF administration prefers not to transfer samples outside of the facility due to legal limitations on biomaterial transfer in/out of Russia. Instead, we favour on-site analysis at our state of the art laboratory.
If you are interested in joining the Vitiligo Biobank network or simply have an existing collection, please contact us to discuss options that may be available to you.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
May 24, 2013: VRF Presentation at EADV Spring Symposium
Sodium oxodihydroacridinylacetate in treatment of active vitiligo. Results of preliminary clinical study.
How can I treat vitiligo?
Choosing a treatment for vitiligo can be difficult, sometimes overwhelming. In general, first-line therapy should be safe, effective, minimally invasive, and cost effi...
What causes vitiligo?
It remains unclear what causes damage to melanocytes and their subsequent total inactivation and/or disappearance in vitiligo skin. There are several theories; the mos...
Is it possible to stop the progression of vitiligo?
Vitiligo is progressive in 73% of cases and regressive in 1.3%. We usually explain to the patients that progression depends on the modality of the disease spreading: l...
I have vitiligo: will my children have vitiligo too?
Although most cases of vitiligo are sporadic, familial clustering is not uncommon, and up to 20% of patients report on the affected relatives. In whites, the lifetime ...